| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
27,438 |
19,267 |
$8.04M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
18,794 |
14,352 |
$4.54M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
7,928 |
5,050 |
$3.60M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
11,407 |
8,016 |
$1.37M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,275 |
5,941 |
$587K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
21,351 |
17,073 |
$527K |
| 80053 |
Comprehensive metabolic panel |
15,693 |
12,935 |
$432K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
2,006 |
1,032 |
$401K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,654 |
3,942 |
$254K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,893 |
639 |
$173K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,716 |
1,409 |
$140K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,267 |
1,665 |
$130K |
| 36415 |
Collection of venous blood by venipuncture |
14,649 |
12,192 |
$121K |
| 73630 |
|
1,384 |
831 |
$111K |
| 71045 |
Radiologic examination, chest; single view |
1,227 |
672 |
$74K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,418 |
2,191 |
$69K |
| 83605 |
|
1,749 |
1,426 |
$59K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
71 |
64 |
$50K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
389 |
265 |
$50K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,472 |
2,119 |
$48K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
769 |
573 |
$42K |
| 84484 |
|
1,331 |
982 |
$41K |
| 81003 |
|
3,932 |
3,438 |
$41K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
4,227 |
3,401 |
$41K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
803 |
726 |
$40K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
285 |
239 |
$39K |
| 71046 |
Radiologic examination, chest; 2 views |
517 |
463 |
$33K |
| 80061 |
Lipid panel |
1,108 |
1,055 |
$32K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
321 |
297 |
$30K |
| 83690 |
|
1,329 |
1,151 |
$29K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,484 |
1,379 |
$28K |
| 83735 |
|
1,481 |
1,233 |
$27K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
87 |
44 |
$20K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
618 |
575 |
$19K |
| 85027 |
|
1,468 |
1,335 |
$18K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
172 |
161 |
$17K |
| 81001 |
|
1,260 |
1,138 |
$16K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
331 |
311 |
$15K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
331 |
311 |
$13K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
368 |
329 |
$12K |
| 81025 |
|
583 |
546 |
$12K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,363 |
1,136 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
607 |
570 |
$10K |
| 87631 |
|
43 |
40 |
$8K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
27 |
24 |
$8K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
443 |
362 |
$8K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
527 |
464 |
$7K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
45 |
25 |
$7K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
611 |
543 |
$6K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
99 |
88 |
$6K |
| 73610 |
|
49 |
43 |
$5K |
| 87186 |
|
186 |
155 |
$4K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
27 |
12 |
$4K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
792 |
649 |
$4K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
287 |
269 |
$3K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
35 |
31 |
$3K |
| 87077 |
|
126 |
108 |
$3K |
| 82728 |
|
63 |
58 |
$3K |
| 59025 |
Fetal non-stress test |
31 |
12 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
187 |
132 |
$2K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
12 |
12 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
59 |
52 |
$2K |
| 86902 |
|
31 |
28 |
$2K |
| 87070 |
|
81 |
78 |
$2K |
| 83880 |
|
100 |
84 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
41 |
36 |
$2K |
| 83550 |
|
38 |
34 |
$1K |
| 99215 |
Prolong outpt/office vis |
70 |
26 |
$1K |
| 83540 |
|
38 |
34 |
$1K |
| 86780 |
|
83 |
79 |
$1K |
| 84439 |
|
55 |
49 |
$1K |
| 82607 |
|
43 |
36 |
$925.12 |
| 85610 |
|
131 |
112 |
$923.03 |
| 86901 |
|
57 |
52 |
$694.73 |
| 86900 |
|
57 |
52 |
$688.47 |
| 73030 |
|
15 |
13 |
$686.03 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
15 |
12 |
$667.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
19 |
13 |
$644.30 |
| 84550 |
|
36 |
28 |
$622.48 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
57 |
53 |
$590.84 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
47 |
40 |
$586.15 |
| 86703 |
|
14 |
14 |
$548.90 |
| 87899 |
|
14 |
14 |
$540.41 |
| 94664 |
|
13 |
12 |
$526.96 |
| 84145 |
|
17 |
12 |
$481.25 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
28 |
27 |
$477.19 |
| 80306 |
|
20 |
17 |
$470.40 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
14 |
12 |
$351.45 |
| 80321 |
|
27 |
17 |
$345.60 |
| J2704 |
Injection, propofol, 10 mg |
15 |
12 |
$301.27 |
| 86140 |
|
14 |
12 |
$281.55 |
| 85730 |
|
19 |
16 |
$260.36 |
| J3490 |
Unclassified drugs |
27 |
24 |
$214.05 |
| 85651 |
|
14 |
12 |
$198.40 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
83 |
65 |
$2.24 |
| 0353U |
|
42 |
38 |
$0.00 |
| A9270 |
Non-covered item or service |
476 |
193 |
$0.00 |